مهندسی پرتو پزشکی و هسته ای ایران
2.45K subscribers
2.54K photos
518 videos
3.33K files
648 links
کانال انجمن پرتو پزشکی
Download Telegram
MEDraysintell Downgrades Proton Therapy Market Projection for 2030

More information 👇

🆔 @partohair
Number of treatment rooms expected by 2030 drops from 1,200 to 900, accounting for financial, regulatory considerations

January 2, 2018 — MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200 to 900. The company said this still represents a 12 percent annual growth from 2017 to 2030, and the need to open an average of more than 50 proton therapy treatment rooms every year from 2018 to 2030.

However, with the growing clinical evidence regarding the efficacy of particle therapy that will progressively be used to treat a broader number of indications, there is room for a further acceleration of the market especially if the industry brings the cost of equipment down, according to the report.

MEDraysintell is delaying the release of the fifth edition of its Proton Therapy World Market Report and Directory to mid-January 2018, when all the latest information will be collected for the last month of 2017. The new edition will provide a comprehensive review of the world market dynamics, with an analysis of both past evolutions and future trends to the year 2030, including a detailed profile of all promoters, manufacturers or developers of proton and carbon therapy equipment.

For more information :
https://www.itnonline.com/content/medraysintell-downgrades-proton-therapy-market-projection-2030

🆔 @partohair
مهلت ثبت نام:20 بهمن ماه 1396
هزینه ثبت نام:اساتید و محققین 150 و دانشجویان 75 هزار تومان
اقامت تحت شرایط خاصی امکان پذیر است.
🆔 @partohair
Report49.pdf
1000.5 KB
Comments on ICRU report No.49:
Stopping powers and ranges for protons and alpha particle

🆔 @partohair
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases

More information 👇

🆔 @partohair
Results indicate the brain receives less dose with radiosurgery, even when treating 10 or more lesions

January 3, 2018 — Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung cancer, growth of the disease in the brain remains a major problem. Radiation is often used to treat deposits in the brain, but the best technique to deliver radiation can be controversial. Whole-brain radiation therapy, as its name suggest, treats the entire brain but can be associated with notable cognitive side effects. Another strategy, radiosurgery, directs highly-focused radiation only to the sites of metastasis, largely sparing the normal brain.

Whole-brain radiation delivers a radiation dose of approximately 30 Gy to the entire brain. A technique known as “hippocampal-sparing” or “hippocampal-avoidance” radiation delivers the same dose of radiation to the bulk of the brain, but only about 10 Gy to the hippocampus. The maximum radiation dose experienced with radiosurgery, even with many metastases, was 1.2 Gy in the hippocampus and 0.8 Gy across the whole brain.

“The very low doses of radiation to the normal brain observed with radiosurgery compared to whole-brain radiation has the potential to dramatically alter the risk of cognitive side effects,” said Rusthoven. “As the field of oncology evolves, we have to evolve with it. Patients with cancer who are eligible for targeted therapies are living longer than ever before, making treatment strategies that support long term quality of life even more important.”

For more information :
https://www.itnonline.com/content/study-compares-radiosurgery-and-whole-brain-radiation-lung-cancer-patients-multiple-brain

🆔 @partohair
زمان ثبت نام: الی 6 بهمن ماه

🆔 @partohair
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer

More information 👇

🆔 @partohair
Prominent cancer centers expand portfolio of patient-centric treatment solutions with Xoft’s painless, scar-free solution

January 2, 2018 — iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based centers from The US Oncology Network – Santa Clarita Radiation Therapy Center and Sherman Oaks Radiation Therapy Center. Local patients with non-melanoma skin cancer (NMSC), including individuals precluded from surgery or those seeking a non-invasive option, will now have access to a proven alternative.

The Xoft technology features a miniaturized, low-energy X-ray source that delivers a precise dose of targeted, isotope-free radiation therapy directly to the lesion, reducing the risk of damage to surrounding healthy tissue. The mobile system can be easily maneuvered from room to room, while minimal shielding requirements enable clinicians to deliver treatment in a standard exam room, offering a highly-efficient, flexible solution.

The Xoft System is cleared by the U.S. Food and Drug Administration (FDA), CE marked and licensed in a growing number of countries for the treatment of cancer anywhere in the body, including NMSC, early-stage breast cancer and gynecological cancers.

For more information :
https://www.itnonline.com/content/california-us-oncology-network-centers-adopt-xoft-electronic-brachytherapy-system-early

🆔 @partohair
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine

More information 👇

🆔 @partohair
Water phantom system enables fast and seamless beam scanning

January 2, 2018 — IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian Halcyon radiation therapy system in Europe to go clinical, at the hospital UZ Leuven in Belgium, using IBA Dosimetry’s Blue Phantom water phantom system.

The Blue Phantom system enables fast and seamless beam scanning workflows that are ideal for verification and annual quality assurance (QA) of the Varian Halcyon. Next to the compact design, the phantom’s conveniently accessible micro-leveling frame enables fast and precise system setup.

For more information :
https://www.itnonline.com/content/blue-phantom-system-used-acceptance-first-european-varian-halcyon-machine

🆔 @partohair
👆👆از دوستانی که علاقه به همکاری در حوزه ی شبیه سازی نسل جدید سلول های خورشیدی هستند در خواست می شود تا علاقمندی و رزومه خود را به ای دی اینجانب ارسال نمایند.
این پروژه در همکاری با محققین دانشگاه UCL انگلستان انجام خواهد شد.
🌐بيشتر آدمها فكر ميكنن موفقيت و شكست دو جاده ى از هم جدا هستن. در صورتيكه هر شكستى ، جاى پا رو براى قدم هاتون تا رسيدن به موفقيت درست ميكنه
ID:@partohair
⬛️ ⬛️
نه نوحی هست
تا از موج و طوفان بَر کشد ما را...
نه موسایی
که بشکافد عصایش آبِ دریا را...
نه ابراهیم
تا ناگه گلستان سازد از آتش...

هموطن تسلیت....

🆔: @partohair